Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New trends in immunosuppression.

Stephen P Cobbold

    International Immunopharmacology
    |December 14, 2004
    PubMed
    Summary

    Immunosuppressive drugs treat organ transplants and autoimmune diseases but cause toxicity and increase infection risks. Research explores transplantation tolerance to overcome these limitations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CD4<sup>+</sup> T Cell Fate Decisions Are Stochastic, Precede Cell Division, Depend on GITR Co-Stimulation, and Are Associated With Uropodium Development.

    Frontiers in immunology·2018
    Same author

    Induced Foxp3(+) T Cells Colonizing Tolerated Allografts Exhibit the Hypomethylation Pattern Typical of Mature Regulatory T Cells.

    Frontiers in immunology·2016
    Same author

    The mTOR pathway and integrating immune regulation.

    Immunology·2013
    Same author

    Regulatory cells and transplantation tolerance.

    Cold Spring Harbor perspectives in medicine·2013
    Same author

    Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers?

    Frontiers in immunology·2012
    Same author

    Foxp3 expression is required for the induction of therapeutic tissue tolerance.

    Journal of immunology (Baltimore, Md. : 1950)·2012

    Area of Science:

    • Immunopharmacology
    • Transplantation immunology
    • Autoimmune disease therapy

    Background:

    • Immunosuppressive agents are crucial for organ transplantation and autoimmune disease management.
    • Current immunosuppressants have significant limitations, including nonspecific toxicity and increased risks of infection and malignancy.
    • Long-term immunosuppression presents challenges in both concept and clinical application.

    Discussion:

    • This special issue features research from the 6th International Conference on New Trends in Immunosuppression.
    • The papers highlight recent advancements, particularly in achieving transplantation tolerance.
    • The complexity of translating experimental findings into effective clinical strategies is a key theme.

    Key Insights:

    • Advances in transplantation tolerance offer potential alternatives to broad immunosuppression.
    • Understanding the limitations of current immunosuppressive therapies is vital for future development.
    • Bridging the gap between experimental research and clinical practice remains a significant challenge.

    Outlook:

    • Future research will likely focus on targeted immunosuppression and tolerance induction.
    • Developing safer and more effective therapeutic strategies for autoimmune diseases and post-transplant care is essential.
    • Continued investigation into the mechanisms of immune tolerance is critical for clinical translation.

    Related Experiment Videos